Conceptio
›
immune-checkpoint-inhibitor
Topic
immune-checkpoint-inhibitor
Knowledge-graph topic
· documents ABOUT immune-checkpoint-inhibitor across the archive
53
Documents about immune-checkpoint-inhibitor
Documents about immune-checkpoint-inhibitor
Time-related biases in observational studies : an illustration with COVID-19 vaccination during immune checkpoint inhibitor therapy
#223942
bioRxiv / medRxiv
Study Protocol to Characterize Symptom Experience During Immune Checkpoint Inhibitor Therapy for Cutaneous Melanoma.
#389015
NCBI PubMed Central
Diagnostic Value of the International Society of Cardio‐Oncology Definition for Suspected Immune Checkpoint Inhibitor–Associated Myocarditis
#677198
HAL (France)
Association of Nutritional Status With Immune Checkpoint Inhibitor Efficacy in Metastatic Metastatic Esophagogastric Cancer.
#915587
ClinicalTrials.gov
Immune checkpoint inhibitor rechallenge after immune-related adverse events: a retrospective study from VigiBase update in 2024 looking for emergent safety signals
#676816
HAL (France)
PD-1 Inhibitor Based Induction Chemotherapy Followed by De-escalation Protocols in OPSCC
#1031752
ClinicalTrials.gov
Exploration of the Predictive Marker and Establishment of Predictive Models of Checkpoint Inhibitor Pneumonitis
#839611
ClinicalTrials.gov
Impact of Dysbiosis-inducing Drugs on Effectivity of Immune Checkpoint Inhibitor in Non-small Cell Lung Cancer Patients
#28340
ClinicalTrials.gov
OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure
#226273
ClinicalTrials.gov
Reprogramming tumour-associated macrophages from immune suppressive to inflammatory state by Checkpoint kinase 1 inhibitor combination treatment
#279383
bioRxiv / medRxiv
VERIFY: Vedolizumab for the Prevention of Immune Checkpoint Inhibitor Related Diarrhea or Colitis in Patients With Cancer
#290993
ClinicalTrials.gov
Immune checkpoint inhibitor-associated myocarditis: a novel risk score
#370841
HAL (France)
TQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd EC
#843144
ClinicalTrials.gov
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
#869553
ClinicalTrials.gov
Immune Checkpoint Inhibitor In High Risk Oral Premalignant Lesions
#896857
ClinicalTrials.gov
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma
#872481
ClinicalTrials.gov
Mortality and Cancer Response in Patients with Immune Check Point Inhibitor Associated Uveitis
#922293
Figshare
A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis
#1008498
ClinicalTrials.gov
Microbial Diversity Between Inflamed and Non-inflamed Skin of Patients With Immune Checkpoint Inhibitor-Induced Dermatitis
#261504
ClinicalTrials.gov
CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC
#283030
ClinicalTrials.gov
Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC
#411392
ClinicalTrials.gov
Prospective Study to Evaluate the Blood Kinetics of Immune Cells and Immunosuppressive Cytokines After Exposure to an Immunity Checkpoint Inhibitor (ICI): Study of the Impact of Chemotherapy
#900704
ClinicalTrials.gov
The role of pathology in immunotherapy and targeted therapy for renal cell carcinoma
#268874
IRIS
Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors
#303750
ClinicalTrials.gov
Impact of Immune Checkpoint Inhibitor-Combined Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer With Brain Metastases
#311895
HAL (France)
Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer
#845458
ClinicalTrials.gov
Exploratory Study on the Therapeutic Effect Prediction Model of Advanced BTC Immunotherapy
#356476
ClinicalTrials.gov
Retrospective Assessment of Adverse Events-related Healthcare Resource Utilization and Costs of Immune Checkpoint Inhibitor and Targeted Therapy for Adjuvant Treatment of Melanoma
#474778
ClinicalTrials.gov
Outcomes With Immune Checkpoint Inhibitor for Patients With Non-Small-Cell Lung Cancer and Stable Brain Metastases
#481763
ClinicalTrials.gov
Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma
#803882
ClinicalTrials.gov
The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities
#842149
ClinicalTrials.gov
Stool Transplant to Control Treatment-related Diarrhea
#870495
ClinicalTrials.gov
Data Sheet 1_Influence of immune checkpoint inhibitor target and timing on combination treatment with antibody-based β-emitting targeted radionuclide therapy across tumor immunogenicity profiles.pdf
#424557
Figshare
PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer
#121352
ClinicalTrials.gov
Trial of Pulsed Electric Field Therapy in Patients With Late-stage Non-small Cell Lung Cancer
#832663
ClinicalTrials.gov
Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC
#995419
ClinicalTrials.gov
Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer
#332741
ClinicalTrials.gov
Efficacy of immune checkpoint inhibitors in paediatric, adolescent and young adults with primary refractory or relapsed classical Hodgkin lymphoma: A national multicentre real‐world study
#239056
HAL (France)
Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer
#287559
ClinicalTrials.gov
Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients
#454034
ClinicalTrials.gov
A Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract Cancer
#467568
ClinicalTrials.gov
Adjuvant Tislelizumab Plus Lenvatinib for Patients at High-risk of HCC Recurrence After Curative Resection or Ablation
#803326
ClinicalTrials.gov
Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma
#860409
ClinicalTrials.gov
Liver Cancer and Immunotherapy in the Liquid Biopsy Era
#208450
ClinicalTrials.gov
Data Management and Sharing Plan for: Identifying cellular and molecular signatures from distinct T cell receptor clonotypes associated with favorable immune checkpoint inhibitor responses in HNSCCs
#282026
UNC Dataverse Dataverse OAI Archive
Correlation Between Pre-transplant ICI Exposure and Post-transplant Graft Rejection
#283057
ClinicalTrials.gov
Impact of Concomitant Use of Steroids and Immune-Checkpoint Inhibitors on Survival Outcomes in NSCLC Patients
#874427
ClinicalTrials.gov
COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research
#172401
ClinicalTrials.gov
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
#180192
ClinicalTrials.gov
A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary
#828891
ClinicalTrials.gov
← Previous
Page 2 of 3
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.